Regeneron Pharmaceuticals, Inc. (LON:0R2M)

Regeneron Pharmaceuticals Statistics

Total Valuation

LON:0R2M has a market cap or net worth of GBP 59.30 billion. The enterprise value is 47.52 billion.

Market Cap	59.30B
Enterprise Value	47.52B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Feb 20, 2026

Share Statistics

Current Share Class	100.80M
Shares Outstanding	n/a
Shares Change (YoY)	-5.65%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	3.79%
Owned by Institutions (%)	88.49%
Float	98.55M

Valuation Ratios

The trailing PE ratio is 17.72 and the forward PE ratio is 16.14.

PE Ratio	17.72
Forward PE	16.14
PS Ratio	5.56
PB Ratio	2.55
P/TBV Ratio	2.66
P/FCF Ratio	19.56
P/OCF Ratio	16.03
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.98, with an EV/FCF ratio of 15.67.

EV / Earnings	14.20
EV / Sales	4.47
EV / EBITDA	14.98
EV / EBIT	17.32
EV / FCF	15.67

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.10.

Current Ratio	4.13
Quick Ratio	3.28
Debt / Equity	0.10
Debt / EBITDA	0.69
Debt / FCF	0.73
Interest Coverage	84.52

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 12.54%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	5.91%
Return on Invested Capital (ROIC)	12.54%
Return on Capital Employed (ROCE)	10.23%
Weighted Average Cost of Capital (WACC)	6.21%
Revenue Per Employee	691,549
Profits Per Employee	217,206
Employee Count	15,410
Asset Turnover	0.37
Inventory Turnover	2.53

Taxes

In the past 12 months, LON:0R2M has paid 539.27 million in taxes.

Income Tax	539.27M
Effective Tax Rate	13.88%

Stock Price Statistics

The stock price has increased by +14.00% in the last 52 weeks. The beta is 0.39, so LON:0R2M's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+14.00%
50-Day Moving Average	763.17
200-Day Moving Average	631.40
Relative Strength Index (RSI)	52.57
Average Volume (20 Days)	621

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.48

Income Statement

In the last 12 months, LON:0R2M had revenue of GBP 10.66 billion and earned 3.35 billion in profits. Earnings per share was 30.82.

Revenue	10.66B
Gross Profit	4.75B
Operating Income	2.75B
Pretax Income	3.89B
Net Income	3.35B
EBITDA	3.15B
EBIT	2.75B
Earnings Per Share (EPS)	30.82

Balance Sheet

The company has 6.39 billion in cash and 2.21 billion in debt, with a net cash position of 11.81 billion.

Cash & Cash Equivalents	6.39B
Total Debt	2.21B
Net Cash	11.81B
Net Cash Per Share	n/a
Equity (Book Value)	23.22B
Book Value Per Share	226.35
Working Capital	10.14B

Cash Flow

In the last 12 months, operating cash flow was 3.70 billion and capital expenditures -667.51 million, giving a free cash flow of 3.03 billion.

Operating Cash Flow	3.70B
Capital Expenditures	-667.51M
Free Cash Flow	3.03B
FCF Per Share	n/a

Margins

Gross margin is 44.57%, with operating and profit margins of 25.81% and 31.41%.

Gross Margin	44.57%
Operating Margin	25.81%
Pretax Margin	36.47%
Profit Margin	31.41%
EBITDA Margin	29.60%
EBIT Margin	25.81%
FCF Margin	28.45%

Dividends & Yields

This stock pays an annual dividend of 2.68, which amounts to a dividend yield of 0.34%.

Dividend Per Share	2.68
Dividend Yield	0.34%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	8.69%
Buyback Yield	5.65%
Shareholder Yield	5.99%
Earnings Yield	5.64%
FCF Yield	5.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R2M has an Altman Z-Score of 6.51 and a Piotroski F-Score of 4.

Altman Z-Score	6.51
Piotroski F-Score	4